Despite a slight deregulation in CLL cells compared with normal B cells, we identified a significant association between TET/IDH gene expression and prognosis, suggesting that epigenetic changes could potentially be associated with disease progression. The gene discussed is IDH2; the disease is B-cell chronic lymphocytic leukemia.